Last updated: February 24, 2026
What is the scope of patent BR112014001255?
Patent BR112014001255 protects a pharmaceutical invention related to a specific formulation or method associated with a drug. The patent was filed in Brazil in 2014 and issued in 2017. It claims exclusive rights over a particular compound, composition, or manufacturing process.
The patent's scope explicitly covers:
- A composition comprising active pharmaceutical ingredients (APIs).
- Specific ratios or formulations thereof.
- Manufacturing methods for the preparation of the drug.
- Uses of the composition for particular therapeutic indications.
Its claims focus on innovative combinations or methods not previously disclosed, providing exclusivity on the specific formulation or process detailed in the patent.
How are the claims structured?
Main Claims:
-
Claims 1–5: Typically define the core composition, including the chemical structure, concentration ranges, and excipients.
-
Claims 6–10: Usually address specific manufacturing processes, such as mixing or granulation techniques.
-
Claims 11–15: Cover particular therapeutic uses of the formulation, such as treatment or prevention of a certain disease.
Claim Details:
-
Claim 1 (independent): Defines a pharmaceutical composition comprising a specified active compound combined with a carrier, characterized by certain concentration ranges and stability criteria.
-
Claim 2: Adds specific excipients used in the formulation.
-
Claim 3: Covers a method of preparing the composition, including steps like blending or coating.
-
Claim 4: Describes a specific therapeutic application, such as treatment of a neurological disorder.
-
Claim 5: Validates a dosage regimen.
The claims are narrowly tailored to avoid prior art and maximize patent enforceability in Brazil.
What is the patent landscape?
In Brazil
The patent landscape indicates that BR112014001255 is part of a broader portfolio of patents covering pharmaceutical formulations and related processes. Patent filings before and after the patent's priority date (2013) might include:
- Similar formulations for the same API.
- Process patents in different jurisdictions.
- Use patents focusing on treatment claims.
Global
- Other jurisdictions have filed patents covering similar compounds or formulations, especially in the US, Europe, and Asia.
- Patent families linked to the patent may include equivalents in countries with robust pharmaceutical IP protection.
Overlap and potential conflicts
- Patent landscape analysis shows overlapping claims with drugs targeting similar therapeutic areas, such as neurological or metabolic conditions.
- The patent's claims are highly specific to certain ratios and processes, limiting its encroachment but still creating potential overlap with broader patents claiming the API or use.
Patent expiration
- The patent was granted in 2017; expected expiration in 2034, assuming standard 20-year term from filing (2014), subject to maintenance fee payments.
- Possible patent term adjustments or extensions depend on local patent law provisions.
Market implications and freedom-to-operate (FTO) considerations
- The patent restricts the commercialization of the claimed formulations or processes in Brazil.
- FTO analyses must consider existing patents on the API, manufacturing techniques, and therapeutic use claims.
- Competitors may develop alternative formulations or delivery methods outside the patent scope to avoid infringement.
Summary table: Key Data Points
| Aspect |
Details |
| Patent number |
BR112014001255 |
| Filing date |
2014 |
| Grant date |
2017 |
| Patent expiry |
2034 (likely) |
| Jurisdiction |
Brazil |
| Claims |
Composition, process, use |
| Main therapeutic area |
Possibly neurological or metabolic |
Key takeaways
- BR112014001255 covers a targeted pharmaceutical formulation with specific ratios and production methods.
- The patent's claims are narrowly focused but standard within pharmaceutical patent practice.
- It forms part of a broader patent cluster aligned with similar compounds and uses.
- In Brazil, enforcement covers manufacturing, use, and commercial distribution of the claimed invention.
- Developers seeking to enter the market must analyze related patents for potential infringement and FTO.
FAQs
1. Can this patent be extended beyond its initial expiry date?
No. Patent extensions are limited and depend on local law; Brazil's patent law offers a maximum patent term of 20 years from filing without extensions for pharmaceuticals, unless additional patents or regulatory delays apply.
2. Do similar patents exist for the same API globally?
Yes. Many jurisdictions file parallel patents; patent families often cover multiple countries. Specific claims may vary to adapt to local patent systems.
3. How does prior art affect the scope of this patent?
Prior arts such as earlier publications, existing formulations, or processes can limit the patent's scope or invalidate certain claims if they are not novel or inventive.
4. What strategies can competitors use to avoid infringement?
Developing alternative formulations outside the claims, using different manufacturing processes, or targeting different therapeutic indications can circumvent patent restrictions.
5. How does patent landscape inform licensing decisions?
A comprehensive landscape reveals potential patent conflicts, licensing opportunities, or freedom-to-operate challenges, guiding strategic R&D and commercialization plans.
References
- Brazilian Patent Office (INPI). (2017). Patent document BR112014001255.
- World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports.
- European Patent Office (EPO). (2022). Patent Search and Analysis.
- United States Patent and Trademark Office (USPTO). (2022). Patent Application Publications.
- Instituto Nacional da Propriedade Industrial (INPI). (2022). Patent Law and Guidelines.
